Rhythm Pharmaceuticals, Inc. (RYTM)
87.79
-2.72
(-3.01%)
USD |
NASDAQ |
Mar 17, 15:03
Rhythm Pharmaceuticals Total Liabilities (Quarterly) : 342.12M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| MannKind Corp. | 843.20M |
| Ligand Pharmaceuticals, Inc. | 543.42M |
| Sarepta Therapeutics, Inc. | 2.209B |
| GeoVax Labs, Inc. | 1.824M |
| Ultragenyx Pharmaceutical, Inc. | 1.605B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 481.19M |
| Shareholders Equity (Quarterly) | 139.07M |
| Debt to Equity Ratio | 1.748 |
| Current Ratio | 4.407 |
| Net Debt Paydown Yield | 0.03% |